Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yenong Cao

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Oncotarget|September 29, 2015
S-nitrosylation and MSC-mediated body compositionYenong Cao, Wayne Balkan, Joshua M Hare
Journal of Thoracic Disease|September 16, 2021
Does denosumab offer survival benefits? -Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitorsYenong Cao, Muhammad Zubair Afzal, Keisuke Shirai
BMJ Case Reports|August 21, 2021
Ipilimumab and nivolumab induced immune-related adverse events in metastatic mucosal melanomaYenong Cao, Muhammad Zubair Afzal, Keisuke Shirai
Thoracic Cancer|June 22, 2023
Integrating POLE/POLD1 mutated for immunotherapy treatment planning of advanced stage non-small cell lung cancerShuhua Zheng, Yenong Cao, James Randall, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2013
Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cellsHuaping Liu, Metin Kurtoglu, Yenong Cao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 13, 2014
NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathyDaniel R Gonzalez, Adriana V Treuer, Guillaume Lamirault, et al.
Journal of Medical Case Reports|August 23, 2023
Clinical presentation of Warburg effect in aggressive lymphoma: a case reportYenong Cao, Margaret C Liu, Emma L Hanlon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
HSR25-151: EPIC Patient Portal Functionality: An Equity Analysis in Vulnerable Cancer PatientsYenong Cao, Marie Noelle Bate Baiyee, Johnson Ching, et al.
JCO Oncology Practice|November 19, 2025
<i>Epic</i> Patient Portal Adoption Among Vulnerable Oncology Patients in the Era of Oral Anticancer MedicationsYenong Cao, Marie Noelle Bate Baiyee, Johnson Ching, et al.
Antioxidants & Redox Signaling|July 15, 2016
GSNOR Deficiency Enhances In Situ Skeletal Muscle Strength, Fatigue Resistance, and RyR1 S-Nitrosylation Without Impacting Mitochondrial Content and ActivityYounghye Moon, Yenong Cao, Jingjing Zhu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Oncotarget|September 29, 2015
S-nitrosylation and MSC-mediated body compositionYenong Cao, Wayne Balkan, Joshua M Hare
Journal of Thoracic Disease|September 16, 2021
Does denosumab offer survival benefits? -Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitorsYenong Cao, Muhammad Zubair Afzal, Keisuke Shirai
BMJ Case Reports|August 21, 2021
Ipilimumab and nivolumab induced immune-related adverse events in metastatic mucosal melanomaYenong Cao, Muhammad Zubair Afzal, Keisuke Shirai
Thoracic Cancer|June 22, 2023
Integrating POLE/POLD1 mutated for immunotherapy treatment planning of advanced stage non-small cell lung cancerShuhua Zheng, Yenong Cao, James Randall, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2013
Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cellsHuaping Liu, Metin Kurtoglu, Yenong Cao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 13, 2014
NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathyDaniel R Gonzalez, Adriana V Treuer, Guillaume Lamirault, et al.
Journal of Medical Case Reports|August 23, 2023
Clinical presentation of Warburg effect in aggressive lymphoma: a case reportYenong Cao, Margaret C Liu, Emma L Hanlon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
HSR25-151: EPIC Patient Portal Functionality: An Equity Analysis in Vulnerable Cancer PatientsYenong Cao, Marie Noelle Bate Baiyee, Johnson Ching, et al.
JCO Oncology Practice|November 19, 2025
<i>Epic</i> Patient Portal Adoption Among Vulnerable Oncology Patients in the Era of Oral Anticancer MedicationsYenong Cao, Marie Noelle Bate Baiyee, Johnson Ching, et al.
Antioxidants & Redox Signaling|July 15, 2016
GSNOR Deficiency Enhances In Situ Skeletal Muscle Strength, Fatigue Resistance, and RyR1 S-Nitrosylation Without Impacting Mitochondrial Content and ActivityYounghye Moon, Yenong Cao, Jingjing Zhu, et al.
Pageof 2